At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
TetraGraphdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Train-of-four Monitoring Using the TetraGraph Neuromuscular Transmission Monitor to Evaluate Rocuronium Infusion Requirements During Major Neurosurgical and Surgical Procedures
In Brief
A clinical study evaluating TetraGraph for Surgery. Completed, enrolled 50 participants across 1 site.
Detailed Summary
This is a prospective, non-blinded study to evaluate rocuronium infusion requirements using the TetraGraph Neuromuscular Transmission Monitor during surgical procedures in patients less than 18 yrs. of age.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSurgery
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20252026
First PostedJun 2024
Enrollment StartSep 2024
Primary CompletionApr 2025
TodayJul 2026
First PostedJun 25, 2024
Enrollment StartSep 12, 2024
Primary CompletionApr 24, 2025
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 2.0 years ago
Interventions
TetraGraphdevice
etraGraph is a unique, EMG-based portable device for quantitative (objective) monitoring of neuromuscular function. It is a precise and easy to use tool for monitoring depth of block, ensuring adequate recovery of muscle function, and aiding the clinician to reduce the incidence of residual block.